ANNOUNCEMENT

MedCity CONVERGE gathers payers, providers, medtech, pharma, digital health, investors, policymakers and more.

Topic: MDG

Rotavirus vaccine is lead target under Medicago, Mitsubishi Tanabe alliance

Rotavirus vaccine is lead target under Medicago, Mitsubishi Tanabe alliance

March 6, 2012 12:34 pm by | 0 Comments

Vaccine developer Medicago (TSX:MDG) will target rotavirus, the leading cause of diarrhea in infants and children worldwide, under a new partnership with Japanese firm Mitsubishi Tanabe Pharma.Medicago stands to gain ... Read more
Rabies virus is next target for vaccine developer Medicago

Rabies virus is next target for vaccine developer Medicago

January 20, 2012 2:29 pm by | 1 Comments

Vaccine maker Medicago (TSX:MDG) has developed a technology that can turn tobacco leaves into vaccines quickly and inexpensively, and the biotechnology company’s new North Carolina site stands ready for influenza ... Read more
Vaccine developer Medicago raises $11M from Philip Morris investment

Vaccine developer Medicago raises $11M from Philip Morris investment

December 16, 2011 1:46 pm by | 0 Comments

Biotechnology company Medicago (TSX:MDG), whose technology makes vaccines from tobacco leaves, now has an additional $11.1 million from an investor who knows a thing or two about the golden leaf: ... Read more
Medicago readies to demo flu vaccine capabilities in new RTP plant

Medicago readies to demo flu vaccine capabilities in new RTP plant

September 13, 2011 11:50 am by | 0 Comments

Biotechnology company Medicago (TSX:MDG) could soon demonstrate whether its technology can rapidly develop and manufacture vaccines to respond to potential pandemic and bioterror threats.Medicago, which is part of a national ... Read more